CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 2,000 shares at an average $35.93 ($71,860)
- 4 Open-market sale General Counsel sold 3,200 shares at $35.25 ($112,800)
- 4 Open-market sale Chief Scientific Officer sold 1,600 shares at $35.00 ($56,000)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $32.34 ($12,936)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 1,200 shares at $29.87 ($35,845)
- 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $29.86 ($223,926)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $31.21 ($12,484)
- 4 Open-market sale General Counsel sold 1,200 shares at $27.00 ($32,400)
- 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $23.92 ($179,419)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $26.76 ($10,704)
- 4 Open-market sale General Counsel sold 1,200 shares at an average $29.40 ($35,282)
- 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $29.37 ($220,248)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $27.74 ($11,096)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 14 · 274 filings